Literature DB >> 15067548

Transient increase in micronucleus frequency and DNA effects in the comet assay in two patients after intoxication with 2,3,7,8-tetrachlorodibenzo- p-dioxin.

Eva Valic1, Oswald Jahn, Olaf Päpke, Robert Winker, Christian Wolf, W Hugo Rüdiger.   

Abstract

BACKGROUND: The genotoxic effects in two patients with 2,3,7,8-tetrachlorodibenzo- p-dioxin (TCDD) intoxication were measured; an association with the workplace was suspected.
METHODS: We determined sister chromatid exchange (SCE), micronuclei (MN) and comet assay tail factor in peripheral lymphocytes of the patients and of control persons.
RESULTS: A determination of polychlorinated dibenzo- p-dioxins (PCDDs) and polychlorinated dibenzofurans (PCDFs) revealed almost pure TCDD at a concentration of 144,000 pg/g blood lipids in patient 1 and 26,000 pg/g blood lipids in patient 2, the first value being the highest level ever reported in humans. The source of TCDD ingestion remains unclear, since TCDD blood levels in 30 employees from the same workplace were in the normal range (1.2-8.6 pg/g blood lipids, average 3.0 pg/g), with the exception of three employees with moderately increased TCDD levels of 93, 149 and 856 pg/g blood lipids, who, however, did not show any clinical symptoms. Systematic measurements of air and equipment did not identify the source of TCDD. We determined SCE and MN in the peripheral lymphocytes of the patients and of control persons. A first determination, a few months after the manifestation of chloracne, showed normal values (2.4 and 2.5 MN/500 binucleated cells; 6.7 +/- 2.2 and 6.0 +/- 2.5 SCEs/metaphase) in both patients. Two months later, when TCDD levels were 85,600 pg/g blood lipids and 17,700 pg/g blood lipids, respectively, MN had increased enormously to 16 and 21.8/500 binucleated cells, SCE remained within normal range. One employee had a TCDD level of 856 pg/g blood lipids but did not develop any clinical symptoms or genotoxic effects, nor did three healthy employees with TCDD levels within background range (1.5-2.9 pg/g blood lipids). Within a period of 13 months, MN had returned to a nearly normal range in both patients. SCE had been within normal ranges all the time. We also determined the comet assay tail factor (DNA damage level) in peripheral lymphocytes of the patients. A first determination, when the TCDD level was 85,600 pg/g blood lipids (proband 1), showed an enormously high value of 33.5%. Nine months later, when the TCDD level was at 73,900 pg/g blood lipids, we found only a moderately increased value of 6.9%. Proband 2 did not have a significantly elevated comet assay tail factor, neither at the TCDD level of 17,700 pg/g blood lipids nor at the level of 15,700 pg/g blood lipids.
CONCLUSIONS: This delayed and transient effect seems to indicate some kind of "indirect" or "secondary" genotoxic effect of TCDD. However, DNA damaging effects, caused directly or indirectly, could be an indicator for a possible carcinogenic risk of TCDD. Copyright 2004 Springer-Verlag

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15067548     DOI: 10.1007/s00420-004-0508-3

Source DB:  PubMed          Journal:  Int Arch Occup Environ Health        ISSN: 0340-0131            Impact factor:   3.015


  15 in total

1.  A simple technique for quantitation of low levels of DNA damage in individual cells.

Authors:  N P Singh; M T McCoy; R R Tice; E L Schneider
Journal:  Exp Cell Res       Date:  1988-03       Impact factor: 3.905

2.  Measurement of micronuclei in lymphocytes.

Authors:  M Fenech; A A Morley
Journal:  Mutat Res       Date:  1985 Feb-Apr       Impact factor: 2.433

3.  Comparison between "Yusho" patients and healthy Japanese in contamination level of dioxins and related chemicals and frequency of sister chromatid exchanges.

Authors:  J Nagayama; M Nagayama; T Iida; H Hirakawa; T Matsueda; M Ohki; H Tsuji
Journal:  Chemosphere       Date:  2001 May-Jun       Impact factor: 7.086

4.  Basal levels of DNA strand breaks in human leukocytes determined by comet assay.

Authors:  Elisabeth Diem; Sabine Ivancsits; Hugo W Rüdiger
Journal:  J Toxicol Environ Health A       Date:  2002-05-10

5.  Olestra increases faecal excretion of 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Authors:  A Geusau; E Tschachler; M Meixner; S Sandermann; O Päpke; C Wolf; E Valic; G Stingl; M McLachlan
Journal:  Lancet       Date:  1999-10-09       Impact factor: 79.321

6.  Hepatotoxic doses of dioxin do not damage mouse bone marrow chromosomes.

Authors:  J Meyne; D C Allison; K Bose; S W Jordan; P F Ridolpho; J Smith
Journal:  Mutat Res       Date:  1985-07       Impact factor: 2.433

7.  The effect of various antioxidants and other modifying agents on oxygen-radical-generated DNA damage in human lymphocytes in the COMET assay.

Authors:  D Anderson; T W Yu; B J Phillips; P Schmezer
Journal:  Mutat Res       Date:  1994-05-01       Impact factor: 2.433

Review 8.  The cytokinesis-block micronucleus technique: a detailed description of the method and its application to genotoxicity studies in human populations.

Authors:  M Fenech
Journal:  Mutat Res       Date:  1993-01       Impact factor: 2.433

Review 9.  An IARC evaluation of polychlorinated dibenzo-p-dioxins and polychlorinated dibenzofurans as risk factors in human carcinogenesis.

Authors:  D B McGregor; C Partensky; J Wilbourn; J M Rice
Journal:  Environ Health Perspect       Date:  1998-04       Impact factor: 9.031

10.  The mechanism of dioxin toxicity: relationship to risk assessment.

Authors:  L S Birnbaum
Journal:  Environ Health Perspect       Date:  1994-11       Impact factor: 9.031

View more
  2 in total

1.  Dioxin induces genomic instability in mouse embryonic fibroblasts.

Authors:  Merja Korkalainen; Katriina Huumonen; Jonne Naarala; Matti Viluksela; Jukka Juutilainen
Journal:  PLoS One       Date:  2012-05-29       Impact factor: 3.240

Review 2.  Toxicological profile of chlorophenols and their derivatives in the environment: the public health perspective.

Authors:  Etinosa O Igbinosa; Emmanuel E Odjadjare; Vincent N Chigor; Isoken H Igbinosa; Alexander O Emoghene; Fredrick O Ekhaise; Nicholas O Igiehon; Omoruyi G Idemudia
Journal:  ScientificWorldJournal       Date:  2013-04-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.